About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6593 record(s)
Req # A-2020-000936
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-109398-915, Update on Canadian Blood Services' MSM Blood and Plasma Research Programs.Organization: Health Canada
October 2020
Req # A-2020-000942
Adverse Reaction Report (AER) for METFORMIN HYDROCHLORIDE. Report number: 000731008.Organization: Health Canada
October 2020
Req # A-2020-000944
Adverse Reaction Reports (AERs). Report numbers: 000682524, 000687867, 000688300, 000690135.Organization: Health Canada
October 2020
Req # A-2020-000983
Adverse Reaction Reports (AERs) for Diclectin (doxylamine succinate / pyridoxine hydrochloride). Report numbers: 000732033, 000909050, 000909091, 000909276, 000909311, 000910666, 000910684, E2B_02965298, E2B_03203772.Organization: Health Canada
October 2020
Req # A-2020-000688
All briefing notes and memos provided to Health Minister Patty Hajdu discussing the development of the COVID-19 vaccine from May 1st 2020 to August 10th 2020. Include all references to “Cansino Biologics” and “Dr. Xuefeng Yu”.Organization: Health Canada
October 2020
Nothing to report this month
Organization: Sustainable Development Technology Canada
Req # A-2014-000213
“2013-14 records identifying legal drugs that led to 10 or more deaths in Canada & 100 or more serious ADR’s in Canada. 2013-14 drug safety review reports that are unavailable online. List of all drug safety reviews done to date. 2013-14 list…Organization: Health Canada
September 2020
Req # A-2015-000361
All Health Canada reviewer reports and notes related to the New Drug Submission for Saxenda® (liraglutide) (DIN 02437899).Organization: Health Canada
September 2020
Req # A-2016-000929
Copy of the current Risk Management Plan for Humira.Organization: Health Canada
September 2020
Req # A-2020-000794
Requesting the rates of male babies and female babies born as a result of fertility treatments, by fertility treatment, for each fertility clinic in Ontario over the last 10 years.Organization: Health Canada
September 2020